Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine effect on oxidative stress and muscle function in COPD
2005-003651-12Phase 3Completed
- Sponsor
- Zambon
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in chronic obstructive pulmonary disease (COPD), sponsored by Zambon. Primary endpoint: Oxidative stress in skeletal and respiratory muscles. Started Sep 2005; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2005-003651-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003651-12.